search
Back to results

Exercise and Acarbose in Type 2 Diabetes

Primary Purpose

Diabetes Mellitus Type 2

Status
Completed
Phase
Phase 4
Locations
Sweden
Study Type
Interventional
Intervention
Acarbose
Exercise
Exercise + Acarbose
Sponsored by
Karolinska Institutet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus Type 2

Eligibility Criteria

45 Years - 60 Years (Adult)All Sexes

Inclusion Criteria: Men and women, diagnosis of type 2 diabetes established since at least three months, treatment with diet or maximum one oral anti-diabetic drug, GHb < 8.5 %, age 45 - 60 years, BMI 25 - 30 kg/m2, no participation in any regular exercise program.

-

Exclusion Criteria: Unable to perform exercise, significant GI-disease, severe heart-disease, renal failure

-

Sites / Locations

  • Enheten för Metabol Kontroll, Endokrinkliniken, Karolinska University Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Experimental

Arm Label

Acarbose

Exercise

Exercise + Acarbose

Arm Description

Outcomes

Primary Outcome Measures

Glycemic control
Glycated A1c

Secondary Outcome Measures

Full Information

First Posted
November 19, 2010
Last Updated
November 19, 2010
Sponsor
Karolinska Institutet
Collaborators
The Swedish Research Council, Bayer
search

1. Study Identification

Unique Protocol Identification Number
NCT01244971
Brief Title
Exercise and Acarbose in Type 2 Diabetes
Official Title
Effect of Exercise Training - Alone or in Combination With Acarbose - on Clinical and Metabolic Factors, and Studies of Cellular and Moleculargenetic Factors, in Type 2 Diabetes.
Study Type
Interventional

2. Study Status

Record Verification Date
December 2003
Overall Recruitment Status
Completed
Study Start Date
January 2004 (undefined)
Primary Completion Date
June 2004 (Actual)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Karolinska Institutet
Collaborators
The Swedish Research Council, Bayer

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to investigate the impact of exercise training, Acarbose, and the combination of exercise and Acarbose on glycemic control, body composition, insulin sensitivity and other cardiovascular risk markers in type 2 diabetes. Further, muscle biopsies will be obtain to study gene expression. Our hypothesis is that the combination therapy will be superior to monotherapy with exercise or Acarbose.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus Type 2

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
62 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Acarbose
Arm Type
Active Comparator
Arm Title
Exercise
Arm Type
Active Comparator
Arm Title
Exercise + Acarbose
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Acarbose
Intervention Description
100mg, 3 times daily
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Intervention Description
Moderate combined exercise, 50 minutes 3 times per week
Intervention Type
Other
Intervention Name(s)
Exercise + Acarbose
Intervention Description
See respective monotherapy description
Primary Outcome Measure Information:
Title
Glycemic control
Description
Glycated A1c
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
60 Years
Eligibility Criteria
Inclusion Criteria: Men and women, diagnosis of type 2 diabetes established since at least three months, treatment with diet or maximum one oral anti-diabetic drug, GHb < 8.5 %, age 45 - 60 years, BMI 25 - 30 kg/m2, no participation in any regular exercise program. - Exclusion Criteria: Unable to perform exercise, significant GI-disease, severe heart-disease, renal failure -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Suad Efendic, Professor
Organizational Affiliation
Dpt of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Official's Role
Study Chair
Facility Information:
Facility Name
Enheten för Metabol Kontroll, Endokrinkliniken, Karolinska University Hospital
City
Stockholm
ZIP/Postal Code
17176
Country
Sweden

12. IPD Sharing Statement

Citations:
PubMed Identifier
16801564
Citation
Wagner H, Degerblad M, Thorell A, Nygren J, Stahle A, Kuhl J, Brismar TB, Ohrvik J, Efendic S, Bavenholm PN. Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes. Diabetes Care. 2006 Jul;29(7):1471-7. doi: 10.2337/dc05-2513.
Results Reference
result

Learn more about this trial

Exercise and Acarbose in Type 2 Diabetes

We'll reach out to this number within 24 hrs